New Partnership to Accelerate the Fight Against Alzheimer’s Disease
World Economic Forum will partner over the next year with the Global CEO Initiative (CEOi) to form a Coalition to accelerate treatments for Alzheimer’s Disease
UsAgainstAlzheimer’s Launches Online Biomarkers Repository to Track Alzheimer’s Research
In an important step to advance Alzheimer’s research, UsAgainstAlzheimer’s today announced the creation of a new online Biomarkers Repository to track research into Alzheimer’s biomarkers and diagnostics. The constantly-evolving Biomarkers Repository will help policymakers, healthcare system leaders and scientific community better understand and support personalized medicine.
The prescription for an effective treatment or cure for Alzheimer’s: More research and cautious optimism
It’s been an exciting few weeks in the Alzheimer’s world – a world that hasn’t seen a new drug in 15 years. All of the activity has raised a lot of questions around the world’s progress toward a cure.
It’s time to pick up the pace on Alzheimer’s prevention
Milken Institute report urges our nation to double down on efforts to reduce the cost and risk of dementia and outlines a series of recommended action steps.
Four Leading Alzheimer’s Organizations Agree on Need For National, Time-Based Prevention Goal
Director of the National Center for Chronic Disease Prevention and Health Promotion, Senior Director of Center for the Future of Aging, and Leading U.S. Alzheimer’s Researcher Resoundingly Support UsAgainstAlzheimer’s Call for a Time-based Alzheimer’s Prevention Goal
UsAgainstAlzheimer’s Applauds Positive News on Alzheimer’s Drug Aducanumab
Statement from George Vradenburg on the announcement by Biogen and Eisai of plans to seek regulatory approval in early 2020 by the Food and Drug Administration (FDA) for aducanumab, an investigational treatment for early Alzheimer’s disease.
UsAgainstAlzheimer’s Brain Health Partnership has issued a Call to Action white paper outlining recommendations for building a better system of care to promote brain health and fight back against Alzheimer’s.
A Vision for Equity in Alzheimer’s Research in 2020
On March 25, 1966 at a press conference before a speech at the second convention of the Medical Committee for Human Rights (MCHR) in Chicago, Martin Luther King said, “Of
Neuroscientist Dr. Yakeel Quiroz was interviewed by the New York Times in November 2019 for a story on a woman with a very rare genetic mutation that has shielded her
The A-LIST transforms the stories of more than 8,000 people living with Alzheimer’s or other dementias into evidence-based insights by providing unique, rapid-response, self-reported data through virtual surveys on what matters most on a wide range of Alzheimer’s-related topics. The A-LIST offers a powerful and validating voice for those living with Alzheimer’s and those caring for them, and a pathway to help expand treatments and accelerate toward a cure.
